Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Circulation: Genomic and Precision Medicine, 2023
Plasma Protein Profiling of Incident Cardiovascular Diseases: A Multisample Evaluation

Lind L., Titova O., Zeng R. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2023
Plasma neurofilament light levels show elevation two years prior to diagnosis of amyotrophic lateral sclerosis in the UK Biobank

Smith E., Lee J., Prilutsky D. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

ESC Heart Failure, 2023
Sex‐specific cardiovascular protein levels and their link with clinical outcome in heart failure

de Bakker M., Loncq de Jong M., Petersen T. et al.

Olink Target 96CVDPathophysiologyPlasma

Journal of Thrombosis and Haemostasis, 2023
Proteomic insights into modifiable risk of venous thromboembolism and cardiovascular comorbidities

Yuan S., Xu F., Zhang H. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Scientific Reports, 2023
Changes in natural killer and T lymphocyte phenotypes in response to cardiovascular risk management

Good E., Åkerman L., Nyström S. et al.

Olink Target 96CVDPathophysiologyPlasma

Pediatric Research, 2023
Antisecretory factor in breastmilk is associated with reduced incidence of sepsis in preterm infants

Gustafsson A., Johansson E., Henckel E. et al.

Olink Target 96Infectious DiseasesObstetricsPathophysiologyPlasma

Nature Communications, 2023
Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation

Mälarstig A., Grassmann F., Dahl L. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

iScience, 2023
Hospital-treated prevalent infections, the plasma proteome and incident dementia among UK older adults

Beydoun M., Beydoun H., Noren Hooten N. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Frontiers in Immunology, 2023
Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay

Kmezic I., Gustafsson R., Fink K. et al.

Olink Target 96NeurologyPatient StratificationPlasmaCSF

iScience, 2023
Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion

Moaddel R., Farmer C., Yavi M. et al.

Olink Explore 3072/384NeurologyPathophysiologyCSF

Brain, 2023
Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains

Quesnel M., Labonté A., Picard C. et al.

Olink Target 96NeurologyPathophysiologyCSF

Scientific Reports, 2023
Galectin-4 is associated with diabetes and obesity in a heart failure population

Dieden A., Gudmundsson P., Korduner J. et al.

Olink Target 96Metabolic DiseasesCVDPatient StratificationPlasma

Scientific Reports, 2023
Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 syndrome with and without postural orthostatic tachycardia syndrome: a multi-omic profiling study

Mahdi A., Zhao A., Fredengren E. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma

Frontiers in Immunology, 2023
Olink proteomics analysis uncovers the landscape of inflammation-related proteins in patients with acute compartment syndrome

Wang T., Yang S., Long Y. et al.

Olink Target 96Other Diseases & SyndromesPatient StratificationSerum

Molecular Neurobiology, 2023
Causal Association of Cytokines and Growth Factors with Stroke and Its Subtypes: a Mendelian Randomization Study

Chen G., Lin T., Wu M. et al.

Olink Target 96CVDPathophysiologyPlasma

European Journal of Cancer, 2023
FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction

van Eijck C., Strijk G., Vietsch E. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Scientific Reports, 2023
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study

Mynster Kronborg T., Webel H., O’Connell M. et al.

Olink Target 96HepatologyPatient StratificationPlasma

Journal of Applied Physiology, 2023
Type 2 diabetes exacerbates changes in blood pressure-independent arterial stiffness: cross-sectional and longitudinal evidence from the SUMMIT study

Aizawa K., Gates P., Mawson D. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

Translational Neurodegeneration, 2023
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer’s disease

Faridar A., Eid A., Thome A. et al.

Olink Target 48NeurologyImmunotherapyPathophysiologyPlasma

European Journal of Heart Failure, 2023
Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program

Ferreira J., Packer M., Butler J. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

3168 publications